Latest Share Purchase Plan News

Brightstar Resources has completed a US$120 million senior secured bond issue, complementing a recent A$193 million equity raise, to fully fund its Goldfields Project and advance the Sandstone Project towards final investment decision.

Magellan Financial Group has successfully raised $130 million through an institutional placement to support its strategic merger with Barrenjoey Capital Partners, with a $20 million share purchase plan also announced for existing shareholders.

Brightstar Resources has successfully upsized its Share Purchase Plan to $18 million, raising total equity proceeds of $193 million to fully fund its Goldfields Project and accelerate development at Sandstone.

Ardea Resources has successfully raised A$5 million through a placement and launched a A$2 million Share Purchase Plan to fund the next phase of its Kalgoorlie Nickel Project. The capital injection supports the finalisation of a key feasibility study and ongoing project development.

Nagambie Resources has opened a discounted Share Purchase Plan aiming to raise $3.7 million to support diamond drilling at its Whroo Mines project and bolster working capital, following a strategic joint venture announcement with Alkane Resources.

Magellan Financial Group has announced a landmark merger with Barrenjoey Capital Partners, creating a diversified financial powerhouse valued at over A$1.6 billion. The deal includes a significant share placement and board reshuffle, setting the stage for expanded market influence.

FBR Limited reports a significant reduction in half-year losses alongside new robotic product launches, yet cash flow challenges raise questions about its financial sustainability.

PARKD Limited reported a 37% revenue decline to $3.88 million for H1 FY2026, driven by the winding down of its flagship Audi Centre Myaree project. The company posted a $1.03 million loss as it invests in East Coast growth and commissions a new prefabrication facility in Penrith, NSW.

Janus Electric Holdings reported a 46% increase in net loss to $4.93 million for the half-year ended December 2025, driven by rising costs despite a 33% revenue boost. The company faces funding uncertainties as it pursues key investments and operational scale-up.

Radiopharm Theranostics reported a 44% increase in net loss to $27 million for the half-year ended December 2025, driven by expanded R&D spending. The company bolstered its cash reserves through a $35 million placement while progressing multiple clinical trials across its radiopharmaceutical pipeline.

Mayfield Group Holdings Ltd has reported a striking 52.8% increase in revenue and a 127.6% jump in profit for the half-year ending December 2025, driven by manufacturing growth and strategic acquisitions.

Actinogen Medical has successfully completed a $16.8 million capital raising, combining a $12 million placement with a $4.8 million share purchase plan, to fund its pivotal Alzheimer’s disease trial and other 2026 initiatives.